Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
56.34-0.15 (-0.27%)
At close: 04:00PM EDT
Advertisement
Sign in to post a message.
  • 1
    100M
    Interesting day given the activity of Vertex today in the M&A space. Go CRSP!
  • s
    spacebee
    Here’s how people got wiped on GME. Trying to stay short until bankruptcy, when bankruptcy wasn’t on the table. Now I see a bunch of biotech with high short interest at all time lows. Some biotech is now under $500 mil market cap but they don’t have debt, How much lower do you want? There’s a bunch $NVTA $BLI $CRSP, etc
    Bullish
  • V
    VanillaBean
    Crispr is back to being a heavy weight in arkk.
  • D
    Dan
    Market will recognize this sector is less associated with inflation and war
  • S
    Simon
    The news wire shows another strategic hire of Dr. P.K Morrow for the final stretch to regulatory approval. Don't miss this important clue. Go CRSP, Goodluck to All CRSP faithful.
    Bullish
  • J
    James
    Data to be presented at EHA. The abstract, as of December 6, 15 of the 17 patients with T-cell lymphoma were able to be evaluated with CTX130. The overall response rate was 71% with 29% of patients experiencing a complete response. It had an acceptable safety profile.
  • A
    AlabamaHobo
    after selling at $63 at loss i bought twice amount of shares in $44.

    Lets hope it does not look back anymore.
  • R
    Rich
    Question: If gene editing is one-and-done, does the longer-term revenue stream from an effective therapy come only from new patients?
  • B
    Brian
    To invest in a company and make money is great. To invest in a company that cures diseases is heavenly.
  • S
    Simon
    CRSP stock price below $50 is a giveaway and a no brainer. Load up if you can and you'll be glad by end of the year.
    Bullish
  • C
    ChrisP
    Green
  • Z
    ZIM
    CONAN says CRSP to $200.00
    Bullish
  • b
    b
    $CRSP is one of my favorite stocks in $ARKG ... so I decided to just buy this at the open instead of ARKG.
  • C
    Cnote
    Cost basis is 125…wake me up in 5 years
  • e
    eric
    CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the 2022 Bank of America Healthcare Conference on Wednesday, May 11, 2022, at 4:40 p.m. PT.
  • J
    James
    6 on going clinical trials going on, and the analyst move price targets down.
  • D
    Dan
    With 2.2 billion cash with 3.5 bill mc, time to accumulate
  • Z
    ZIM
    "WHERE IS CRSP EARNINGS????"
    CRISPR THERAPEUTICS IS IN THE RESEARCH & DEVELOPEMENT STAGE.
    APPLYING FOR FDA APPROVAL, 4TH QTR FOR CTX001

    CRSP / CRBU / NTLA
    SUPPORT THE NOBEL LAUREATES.
    NOT THE BROAD
    Bullish
Advertisement
Advertisement